Page last updated: 2024-08-18

pyrroles and decitabine

pyrroles has been researched along with decitabine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Giles, FJ	1
Berkova, Z; Koblas, T; Leontovyč, I; Pektorova, L; Saudek, F; Zacharovova, K	1
Advani, AS; Bixby, D; DeAngelo, DJ; Erba, HP; Faderl, S; Fathi, AT; Ho, PA; Jillella, A; Kovacsovics, TJ; Lancet, JE; Levy, MY; O'Meara, MM; Ravandi, F; Stein, AS; Stein, EM; Voellinger, J; Walter, RB	1
Ayers, GD; Cirici, BX; Cross, NCP; Dezern, AE; Elena, C; Fenaux, P; Geissler, K; Gerds, AT; Germing, U; Itzykson, R; Kiladjian, JJ; Kishtagari, A; Komrokji, RS; Luebbert, M; Mendler, JH; Mesa, RA; Montalban-Bravo, G; Moyo, TK; Nazha, A; Onida, F; Padron, E; Patnaik, MM; Pfeilstöecker, M; Platzbecker, U; Pleyer, L; Santini, V; Sanz, GF; Savona, MR; Seegmiller, AC; Solary, E; Steensma, DP; Tibes, R; Valent, P; van de Loosdrecht, AA; Wiseman, DH; Zhang, J	1

Reviews

1 review(s) available for pyrroles and decitabine

Article	Year
New drugs in acute myeloid leukemia. Current oncology reports, 2002, Volume: 4, Issue:5 Topics: Acute Disease; Adenine Nucleotides; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Bevacizumab; Boronic Acids; Bortezomib; Clofarabine; Cytosine; Decitabine; Dioxolanes; Humans; Indoles; Leukemia, Myeloid; Phthalazines; Pyrazines; Pyridines; Pyrroles; Thionucleotides	2002

Article

Year

New drugs in acute myeloid leukemia.

Current oncology reports, 2002, Volume: 4, Issue:5

Topics: Acute Disease; Adenine Nucleotides; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Bevacizumab; Boronic Acids; Bortezomib; Clofarabine; Cytosine; Decitabine; Dioxolanes; Humans; Indoles; Leukemia, Myeloid; Phthalazines; Pyrazines; Pyridines; Pyrroles; Thionucleotides

2002

Trials

2 trial(s) available for pyrroles and decitabine

Article	Year
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML. Blood, 2018, 09-13, Volume: 132, Issue:11 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzodiazepines; Decitabine; Disease-Free Survival; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm, Residual; Pyrroles; Sialic Acid Binding Ig-like Lectin 3; Survival Rate	2018
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes. BMC cancer, 2022, Sep-24, Volume: 22, Issue:1 Topics: Acetonitriles; Cytidine Deaminase; Decitabine; DNA; Humans; Methyltransferases; Myelodysplastic-Myeloproliferative Diseases; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles; Quality of Life; Syndrome	2022

Article

Year

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.

Blood, 2018, 09-13, Volume: 132, Issue:11

Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzodiazepines; Decitabine; Disease-Free Survival; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm, Residual; Pyrroles; Sialic Acid Binding Ig-like Lectin 3; Survival Rate

2018

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.

BMC cancer, 2022, Sep-24, Volume: 22, Issue:1

Topics: Acetonitriles; Cytidine Deaminase; Decitabine; DNA; Humans; Methyltransferases; Myelodysplastic-Myeloproliferative Diseases; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles; Quality of Life; Syndrome

2022

Other Studies

1 other study(ies) available for pyrroles and decitabine

Article	Year
The effect of epigenetic factors on differentiation of pancreatic progenitor cells into insulin-producing cells. Transplantation proceedings, 2011, Volume: 43, Issue:9 Topics: Azacitidine; Azepines; C-Peptide; Cell Culture Techniques; Cell Differentiation; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Keratin-19; Models, Biological; Models, Genetic; Pancreas; Pyrroles; Quinazolines; Stem Cells; Transcription Factors	2011

Article

Year

The effect of epigenetic factors on differentiation of pancreatic progenitor cells into insulin-producing cells.

Transplantation proceedings, 2011, Volume: 43, Issue:9

Topics: Azacitidine; Azepines; C-Peptide; Cell Culture Techniques; Cell Differentiation; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Keratin-19; Models, Biological; Models, Genetic; Pancreas; Pyrroles; Quinazolines; Stem Cells; Transcription Factors

2011